Search Results for "ezetimibe"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for ezetimibe. Results 21 to 23 of 23 total matches.
See also: Vytorin, Zetia

New Simvastatin Dosing Recommendations

   
The Medical Letter on Drugs and Therapeutics • Aug 08, 2011  (Issue 1370)
with other drugs.1 Simvastatin is available alone (Zocor, and others) and in combination with ezetimibe (Vytorin ...
The FDA has announced changes in the labeling of simvastatin to reduce the risk of myopathy. These changes include limiting the use of the 80-mg maximum dose to patients who have been taking it for 12 months or more without evidence of myopathy and new recommendations for use of simvastatin with other drugs. Simvastatin is available alone (Zocor, and others) and in combination with ezetimibe (Vytorin) and with niacin (Simcor).
Med Lett Drugs Ther. 2011 Aug 8;53(1370):61-2 |  Show IntroductionHide Introduction

What about Niacin?

   
The Medical Letter on Drugs and Therapeutics • Nov 28, 2011  (Issue 1378)
mg/day and, if needed, ezetimibe (Zetia) 10 mg/day to lower their LDL-C to the range of 40-80 mg/dL ...
The results of the AIM-HIGH trial conducted by the US National Heart, Lung and Blood Institute (NHLBI) were recently published. The goal of the trial was to test whether addition of niacin to intensive statin therapy would further reduce the risk of cardiovascular disease. The trial was stopped prematurely after an average follow-up of 3 years because niacin therapy had not shown any clinical benefit.
Med Lett Drugs Ther. 2011 Nov 28;53(1378):93-4 |  Show IntroductionHide Introduction

Cholesterol Rethink for High-Risk Patients

   
The Medical Letter on Drugs and Therapeutics • May 10, 2004  (Issue 1182)
a statin with another LDL-lowering drug, such as ezetimibe (Zetia), colesevelam (Welchol) or niacin ...
The recent "PROVE IT" trial in patients with coronary heart disease showed clinical benefits associated with reducing LDL cholesterol concentrations lower than the 100 mg/dL (2.59 mmol/L) or less that had been considered optimal.
Med Lett Drugs Ther. 2004 May 10;46(1182):37-9 |  Show IntroductionHide Introduction